pubmed-article:12003248 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12003248 | lifeskim:mentions | umls-concept:C0002395 | lld:lifeskim |
pubmed-article:12003248 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
pubmed-article:12003248 | lifeskim:mentions | umls-concept:C0542559 | lld:lifeskim |
pubmed-article:12003248 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:12003248 | lifeskim:mentions | umls-concept:C1709630 | lld:lifeskim |
pubmed-article:12003248 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:12003248 | pubmed:dateCreated | 2002-5-10 | lld:pubmed |
pubmed-article:12003248 | pubmed:abstractText | The aim of the study was to investigate whether the preclinical stage of Alzheimer's disease (AD) can be diagnosed in a clinical setting. To this end we investigated whether subjects with preclinical AD could be differentiated from subjects with nonprogressive mild cognitive impairment and from subjects with very mild AD-type dementia. | lld:pubmed |
pubmed-article:12003248 | pubmed:language | eng | lld:pubmed |
pubmed-article:12003248 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12003248 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12003248 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12003248 | pubmed:month | Dec | lld:pubmed |
pubmed-article:12003248 | pubmed:issn | 1041-6102 | lld:pubmed |
pubmed-article:12003248 | pubmed:author | pubmed-author:JollesJJ | lld:pubmed |
pubmed-article:12003248 | pubmed:author | pubmed-author:PondsR WRW | lld:pubmed |
pubmed-article:12003248 | pubmed:author | pubmed-author:VerheyF RFR | lld:pubmed |
pubmed-article:12003248 | pubmed:author | pubmed-author:VisserP JPJ | lld:pubmed |
pubmed-article:12003248 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12003248 | pubmed:volume | 13 | lld:pubmed |
pubmed-article:12003248 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12003248 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12003248 | pubmed:pagination | 411-23 | lld:pubmed |
pubmed-article:12003248 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:meshHeading | pubmed-meshheading:12003248... | lld:pubmed |
pubmed-article:12003248 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:12003248 | pubmed:articleTitle | Diagnosis of preclinical Alzheimer's disease in a clinical setting. | lld:pubmed |
pubmed-article:12003248 | pubmed:affiliation | Department of Psychiatry and Neuropsychology, University of Maastricht, The Netherlands. pj.visser@np.unimaas.nl | lld:pubmed |
pubmed-article:12003248 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12003248 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12003248 | lld:pubmed |